Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Organovo Holdings Inc. (ONVO)

Biological Products, (no Disgnostic Substances)

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

11555 SORRENTO VALLEY ROAD, SUITE 100
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/16/2011

Market Cap

8,480,983

Shares Outstanding

8,840,000

Weighted SO

9,805,709

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

SSYS --.--%

VJET --.--%

DDD --.--%

PRLB --.--%

MTLS --.--%

Beta

0.6760

Last Div

0.0000

Range

0.5-2.05

Chg

-0.0060

Avg Vol

118567

Mkt Cap

8480983

Exch

NASDAQ

Country

US

Phone

858 224 1000

DCF Diff

0.4111

DCF

0.1569

Div Yield

0.0000

P/S

116.1778

EV Multiple

-0.2532

P/FV

1.2150

Div Yield %

0.0000

P/E

-0.5787

PEG

-0.0302

Payout

0.0000

Current Ratio

3.5824

Quick Ratio

3.3817

Cash Ratio

3.0433

DSO

240.0000

DIO

524.3662

Op Cycle

764.3662

DPO

1438.1514

CCC

-673.7852

Gross Margin

-2.8904

Op Margin

-195.5753

Pretax Margin

-191.5753

Net Margin

-191.6027

Eff Tax Rate

0.0001

ROA

-1.4770

ROE

-2.2468

ROCE

-1.9197

NI/EBT

1.0001

EBT/EBIT

0.9795

EBIT/Rev

-195.5753

Debt Ratio

0.1357

D/E

0.1929

LT Debt/Cap

0.1042

Total Debt/Cap

0.1617

Int Coverage

0.0000

CF/Debt

-9.5914

Equity Multi

1.4215

Rec Turnover

1.5208

Pay Turnover

0.2538

Inv Turnover

0.6961

FA Turnover

0.0407

Asset Turnover

0.0077

OCF/Share

-0.8405

FCF/Share

-0.8424

Cash/Share

0.4219

OCF/Sales

-168.8356

FCF/OCF

1.0022

CF Coverage

-9.5914

ST Coverage

-24.1667

CapEx Coverage

-456.4815

Div&CapEx Cov

-456.4815

P/BV

1.2150

P/B

1.2150

P/S

116.1778

P/E

-0.5787

P/FCF

-0.6866

P/OCF

-0.6567

P/CF

-0.6567

PEG

-0.0302

P/S

116.1778

EV Multiple

-0.2532

P/FV

1.2150

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation